BioLegend: Empower your Research

Cancer research is complicated. Build your experiments on solid ground.

The Scientist

| 1 min read

Listen with Speechify

0:00

1:00

Cancer research is complicated. Build your experiments on solid ground. Trust your tools and empower your research. Visit BioLegend at AACR at Booth #1147 and learn more at biolegend.com/cancer

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!

Join for free today

Already a member? Login Here

January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue

Research Resources

Sex Differences in Neurological Research

Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.

New Frontiers in Vaccine Development

Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.

New Approaches for Decoding Cancer at the Single-Cell Level

In this webinar, Linghua Wang and Jeremy Goecks will talk about technology that enables new approaches for a better understanding of tumors on a cellular, spatial, and environmental level.

Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research

Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.

Products

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Partnership complements Sapient’s mass spectrometry-based proteomics services, extends multi-omics solutions, and will enable development of NULISAseq™ assays under regulated guidance

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 and 8, enabling determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) samples.

An illustration of different-shaped bacteria.

Leveraging PCR for Rapid Sterility Testing

PCR-based sterility methods can quickly and sensitively detect bacterial and fungal contamination.

Conceptual 3D image of DNA on a blue background.

Understanding the Nuts and Bolts of qPCR Assay Controls

Explore how the design and application of appropriate assay controls ensure accurate and reproducible qPCR results.

We’ve updated our Privacy Policy to make it clearer how we use your personal data.

Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.

BioLegend: Empower your Research

The Scientist ARCHIVES

Become a Member of

Related Research Resources

Why Do Some People Get Drunk Faster Than Others?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks